Combination treatment of cancer with cetuximab and tetrac

Hung-Yun Lin (发明人), Faith B. Davis (发明人), Paul J. Davis (发明人), Shaker A. Mousa (发明人)

研究成果: 專利

摘要

Provided herein are compositions and methods for treating cancer by increasing the inhibitory effect of cetuximab on HIF1α expression by administering cetuximab in combination with anti-angiogenic thyroid hormone analogs such as tetrac or triac.
原文英語
出版狀態已發佈 - 2010

指紋

Thyroid Hormones
Neoplasms
Cetuximab
tetraiodothyroacetic acid
3,3',5-triiodothyroacetic acid

引用此文

Lin, H-Y., B. Davis, F., J. Davis, P., & A. Mousa, S. (2010). Combination treatment of cancer with cetuximab and tetrac.

Combination treatment of cancer with cetuximab and tetrac. / Lin, Hung-Yun (发明人); B. Davis, Faith (发明人); J. Davis, Paul (发明人); A. Mousa, Shaker (发明人).

研究成果: 專利

Lin, H-Y, B. Davis, F, J. Davis, P & A. Mousa, S 2010, Combination treatment of cancer with cetuximab and tetrac.
Lin H-Y, B. Davis F, J. Davis P, A. Mousa S, 發明者. Combination treatment of cancer with cetuximab and tetrac. 2010.
Lin, Hung-Yun (发明人) ; B. Davis, Faith (发明人) ; J. Davis, Paul (发明人) ; A. Mousa, Shaker (发明人). / Combination treatment of cancer with cetuximab and tetrac.
@misc{40c88d1231914ee2b4b8c54bc016f246,
title = "Combination treatment of cancer with cetuximab and tetrac",
abstract = "Provided herein are compositions and methods for treating cancer by increasing the inhibitory effect of cetuximab on HIF1α expression by administering cetuximab in combination with anti-angiogenic thyroid hormone analogs such as tetrac or triac.",
author = "Hung-Yun Lin and {B. Davis}, Faith and {J. Davis}, Paul and {A. Mousa}, Shaker",
year = "2010",
language = "English",
type = "Patent",

}

TY - PAT

T1 - Combination treatment of cancer with cetuximab and tetrac

AU - Lin, Hung-Yun

AU - B. Davis, Faith

AU - J. Davis, Paul

AU - A. Mousa, Shaker

PY - 2010

Y1 - 2010

N2 - Provided herein are compositions and methods for treating cancer by increasing the inhibitory effect of cetuximab on HIF1α expression by administering cetuximab in combination with anti-angiogenic thyroid hormone analogs such as tetrac or triac.

AB - Provided herein are compositions and methods for treating cancer by increasing the inhibitory effect of cetuximab on HIF1α expression by administering cetuximab in combination with anti-angiogenic thyroid hormone analogs such as tetrac or triac.

M3 - Patent

ER -